MétaCan
Menu
← Back to cohort
Record W6992789536

Meta-analysis of efficacy and safety of Donepezil in treating cognitive decline of Parkinson's disease

2021· article· en· W6992789536 on OpenAlexaboutno aff

Bibliographic record

VenueDOAJ (DOAJ: Directory of Open Access Journals) · 2021
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsDonepezilSubgroup analysisCognitive declineAdverse effectDiseaseRandomized controlled trialCognition
DOInot available

Abstract

fetched live from OpenAlex

Objective: To systematically evaluate the efficacy and safety of Donepezil in treating the \ncognitive decline in patients with Parkinson's disease (PD). Methods: Nine literature databases \nin domestic and abroad were searched by computer, and the search deadline was November \n2, 2020. The randomized controlled trials (RCT) using donepezil to treat the cognitive decline \nin patients with PD were screened. The MMSE (Mini-Mental State Exam) scores, MoCA \n(Montreal Cognitive Assessment) scores and adverse events of the included RCTs were \nextracted. Meta-analysis was implemented with RevMan 5.3 software, and the subgroup \nanalyses were conducted to evaluate the effects of mean age and mean course of disease on \nthe MMSE scores. Results: 14 RCTs with 1263 patients were selected, including 646 cases in \nthe experimental group and 617 cases in the control group. There were 1209 effective patients \nwho completed MMSE score, including 612 in the experimental group and 597 in the control \ngroup. Meta-analysis results showed that MMSE scores in the experimental group were \nhigher than that in the control group after using donepezil intervention, and the difference was \nstatistically significant [SMD=0.55, 95% CI (0.24, 0.87), P=0.0006]. It was also found that \nthe MoCA scores of experimental group were higher than that of control group after using \ndonepezil intervention, and the difference was statistically significant [SMD=1.25,95% CI \n(0.79, 1.72),P<0.00001]. Subgroup analysis showed that donepezil improved MMSE scores in \ndifferent subgroups, and the difference between each group was statistically significant. There \nwas no heterogeneity in the subgroup of mean age lower than 65 years, and the heterogeneity \nexisted between the subgroup of mean course of disease lower than 3 years and the subgroup \nof mean course of disease larger than or equal to 3 years. For adverse events, the incidence of \nadverse events in the experimental group was 22.18%. There was no heterogeneity between \nthe included studies (I2=0%), and the difference was not statistically significant [RR=1.18, 95% \nCI (0.95, 1.47), P=0.14]. Conclusion: The results of meta-analysis showed that donepezil can \nimprove the cognitive decline in patients with Parkinson's disease significantly, and it has good \nsafety.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.022
metaresearch head score (Gemma)0.035
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.022
Threshold uncertainty score0.118

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0220.035
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0210.053
Bibliometrics0.0060.005
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.269
GPT teacher head0.525
Teacher spread0.256 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueDOAJ (DOAJ: Directory of Open Access Journals)→Same topicParkinson's Disease Mechanisms and Treatments→French-language works237,207→